GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
F

Fulcrum Therapeutics FULC · USD

Health Care · US listing · 🇺🇸 United States

Compare

3.72

+0.54%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Fulcrum Therapeutics

Our reporting

We have not reported on Fulcrum Therapeutics yet.

Next results

2 Mar 2027

Due on 2 Mar 2027. Analysts expect earnings of -0.05 a share.

Past results

Reported against what analysts expected

30 Jul 202627 Apr 202624 Feb 202629 Oct 202529 Jul 20251 May 2025
Earnings per share-0.34-0.25-0.31-0.31-0.28-0.28
Forecast-0.24-0.31-0.31-0.29-0.29-0.29

Key events

  1. 18 Jul 2019Listed

Fulcrum Therapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.